UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Definitive Results of a Phase III Adjuvant Trial Comparing Three Chemotherapy Regimens in Women With Operable, Node-Positive Breast Cancer: The NSABP B-38 Trial

Journal of clinical oncology, 2013-09, Vol.31 (26), p.3197-3204

2013

Volltextzugriff (PDF)

Liquid air energy storage systems: A review

Renewable & sustainable energy reviews, 2021-08, Vol.146, p.111113, Article 111113

2021

Volltextzugriff (PDF)

Epileptic dyskinetic encephalopathy in KBG syndrome: Expansion of the phenotype

Epilepsy & behavior reports, 2024-01, Vol.25, p.100647, Article 100647

2024

Volltextzugriff (PDF)

Macrocephaly Following the Bidirectional Glenn Procedure

The Journal of pediatrics, 2024-02, Vol.265, p.113804, Article 113804

2024

Volltextzugriff (PDF)

Thrombolysis and Iliofemoral Vein Stent Placement in Cancer Patients with Lower Extremity Swelling Attributed to Lymphedema

Journal of vascular and interventional radiology, 2015, Vol.26 (1), p.39-45

2015

Volltextzugriff (PDF)

Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy – The GCIG symptom benefit study (SBS)

Gynecologic oncology, 2020-01, Vol.156 (1), p.45-53

2020

Volltextzugriff (PDF)

The 2017 and 2022 ILAE epilepsy classification systems identify needs and opportunities in care: A paediatric hospital-based study

Epilepsy & behavior, 2024-08, Vol.157, p.109804, Article 109804

2024

Volltextzugriff (PDF)

MON-PP004: The Impact of Body Composition Parameters on Ipilimumab Toxicity in Metastatic Melanoma and Longitudinal Changes in Body Composition During Treatment

Clinical nutrition (Edinburgh, Scotland), 2015-09, Vol.34, p.S128-S128

2015

Volltextzugriff (PDF)

3339 The impact of body composition parameters on ipilimumab toxicity in metastatic melanoma and longitudinal changes in body composition during treatment

European journal of cancer (1990), 2015-09, Vol.51, p.S679-S679

2015

Volltextzugriff (PDF)

Aromatase inhibitors and arthralgia

Journal of clinical oncology, 2001-05, Vol.19 (10), p.2767

2001

Volltextzugriff (PDF)

1964 Pilot study of bevacizumab (Bev) in combination with docetaxel (T) and cyclophosphamide (C) as adjuvant treatment (AdjRx) for patients (pts) with early stage (ES) HER-2 normal breast cancer (BrCa) ICORG 08-10

European journal of cancer (1990), 2015-09, Vol.51, p.S321-S321

2015

Volltextzugriff (PDF)

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

The New England journal of medicine, 2017-11, Vol.377 (19), p.1824-1835

2017

Volltextzugriff (PDF)

A review of sentinel lymph node biopsy for thin melanoma

Irish journal of medical science, 2015-03, Vol.184 (1), p.119-123

2015

Volltextzugriff (PDF)

1986P MDM2 amplification and hyperprogression following treatment with immune checkpoint inhibitors in advanced non-small cell lung cancer

Annals of oncology, 2020-09, Vol.31, p.S1112-S1113

2020

Volltextzugriff (PDF)

How long have we got? The accuracy of physicians’ estimates and scenarios for survival time in 898 women with recurrent ovarian cancer (ROC)

JOURNAL OF CLINICAL ONCOLOGY, 2019, Vol.37 (15_suppl), p.5549-5549

2019

Volltextzugriff (PDF)

7162 POSTER A Pan-European Study of Treatment (trx) Patterns and Toxicity of Angiogenesis Inhibitors in Patients (pts) With Advanced Renal Cell Carcinoma (RCC)

European journal of cancer (1990), 2011, Vol.47, p.S524-S524

2011

Volltextzugriff (PDF)

GuardIVa: a novel antimicrobial haemostatic IV dressing: Part 2

British journal of nursing (Mark Allen Publishing), 2012-02, Vol.21 (2), p.S16-S21

2012

Volltextzugriff (PDF)

Internal energy and exergy recovery in high temperature application absorption heat transformers

Applied thermal engineering, 2013-07, Vol.56 (1-2), p.1-10

2013

Volltextzugriff (PDF)

Predictors of stopping chemotherapy early and short survival in patients with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) who have had ≥3 lines of prior chemotherapy: The GCIG symptom benefit study (SBS)

JOURNAL OF CLINICAL ONCOLOGY, 2017, Vol.35 (15_suppl), p.5575-5575

2017

Volltextzugriff (PDF)

Hidden in plain sight – Survival consequences of baseline symptom burden in women with recurrent ovarian cancer

Gynecologic oncology, 2024-06, Vol.185, p.128-137

2024

Volltextzugriff (PDF)

Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) – Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS)

Gynecologic oncology, 2018-01, Vol.148 (1), p.36-41

2018

Volltextzugriff (PDF)

Comparison of the effect of two types of acupuncture on quality of life in secondary progressive multiple sclerosis: a preliminary single-blind randomized controlled trial

Clinical rehabilitation, 2008-03, Vol.22 (3), p.195-205

2008

Volltextzugriff (PDF)

Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study

International journal of gynecological cancer, 2022-06, Vol.32 (6), p.761-768

2022

Volltextzugriff (PDF)

Baseline quality of life (QOL) as a predictor of stopping chemotherapy early, and of overall survival, in platinum-resistant/refractory ovarian cancer (PRROC): The GCIG symptom benefit study (SBS)

JOURNAL OF CLINICAL ONCOLOGY, 2016, Vol.34 (15_suppl), p.5508-5508

2016

Volltextzugriff (PDF)

Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer

Quality of life research, 2018-01, Vol.27 (1), p.59-74

2018

Volltextzugriff (PDF)

1 – 25 von 411

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(360)
Mit Volltextzugriff
(332)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(410)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Definitive Results of a Phase III Adjuvant Trial Comparing Three Chemotherapy Regimens in Women With Operable, Node-Positive Breast Cancer: The NSABP B-38 Trial

Liquid air energy storage systems: A review

Epileptic dyskinetic encephalopathy in KBG syndrome: Expansion of the phenotype

Macrocephaly Following the Bidirectional Glenn Procedure

Thrombolysis and Iliofemoral Vein Stent Placement in Cancer Patients with Lower Extremity Swelling Attributed to Lymphedema

Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy – The GCIG symptom benefit study (SBS)

The 2017 and 2022 ILAE epilepsy classification systems identify needs and opportunities in care: A paediatric hospital-based study

MON-PP004: The Impact of Body Composition Parameters on Ipilimumab Toxicity in Metastatic Melanoma and Longitudinal Changes in Body Composition During Treatment

3339 The impact of body composition parameters on ipilimumab toxicity in metastatic melanoma and longitudinal changes in body composition during treatment

Aromatase inhibitors and arthralgia

1964 Pilot study of bevacizumab (Bev) in combination with docetaxel (T) and cyclophosphamide (C) as adjuvant treatment (AdjRx) for patients (pts) with early stage (ES) HER-2 normal breast cancer (BrCa) ICORG 08-10

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

A review of sentinel lymph node biopsy for thin melanoma

1986P MDM2 amplification and hyperprogression following treatment with immune checkpoint inhibitors in advanced non-small cell lung cancer

How long have we got? The accuracy of physicians’ estimates and scenarios for survival time in 898 women with recurrent ovarian cancer (ROC)

7162 POSTER A Pan-European Study of Treatment (trx) Patterns and Toxicity of Angiogenesis Inhibitors in Patients (pts) With Advanced Renal Cell Carcinoma (RCC)

GuardIVa: a novel antimicrobial haemostatic IV dressing: Part 2

Internal energy and exergy recovery in high temperature application absorption heat transformers

Predictors of stopping chemotherapy early and short survival in patients with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) who have had ≥3 lines of prior chemotherapy: The GCIG symptom benefit study (SBS)

Hidden in plain sight – Survival consequences of baseline symptom burden in women with recurrent ovarian cancer

Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) – Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS)

Comparison of the effect of two types of acupuncture on quality of life in secondary progressive multiple sclerosis: a preliminary single-blind randomized controlled trial

Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study

Baseline quality of life (QOL) as a predictor of stopping chemotherapy early, and of overall survival, in platinum-resistant/refractory ovarian cancer (PRROC): The GCIG symptom benefit study (SBS)

Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer

Suchergebnisse filtern